Mostrar el registro sencillo del ítem

dc.contributor.authorPintos, Ilduara
dc.contributor.authorMoreno-Torres, Víctor
dc.contributor.authorIbánez-Estéllez, Fatima
dc.contributor.authorCorrales-Rodriguez, Pilar
dc.contributor.authorTreviño, Ana
dc.contributor.authorCorpas, Manuel
dc.contributor.authorCorral, Octavio Jorge
dc.contributor.authorSoriano, Vicente
dc.contributor.authorde Mendoza, Carmen
dc.date2022
dc.date.accessioned2023-04-11T12:06:40Z
dc.date.available2023-04-11T12:06:40Z
dc.identifier.citationPintos-Pascual, I., Moreno-Torres, V., Ibánez-Estéllez, F., Corrales-Rodriguez, P., Treviño, A., Corpas, M., ... & de Mendoza, C. (2022). Is SARS-CoV-2 the only cause of long-COVID?. AIDS rev.es_ES
dc.identifier.issn1139-6121
dc.identifier.urihttps://reunir.unir.net/handle/123456789/14505
dc.description.abstractAround 10% of adults infected with SARS-CoV-2 that survive a first episode of COVID-19 appear to experience long-term clinical manifestations. The signs and symptoms of this post-acute COVID-19 syndrome (PACS) include fatigue, dyspnea, joint pain, myalgia, chest pain, cough, anosmia, dysgeusia, headache, depression, anxiety, memory loss, concentration difficulties, and insomnia. These sequelae remind the constellation of clinical manifestations previously recognized as myalgic encephalomyelitis (ME) or chronic fatigue syndrome (CFS). This condition has been described following distinct infectious events, mostly acute viral illnesses. In this way, the pathophysiology of PACS might overlap with mechanisms involved in other post-infectious fatigue syndromes. The risk of PACS is more frequent in women than men. Additional host genetic factors could be involved. There is a dysregulation of multiple body organs and systems, involving the immune system, the coagulation cascade, endocrine organs, autonomic nervous system, microbiota–gut–brain axis, hypotha-lamic–pituitary–adrenal axis, hypothalamic–pituitary–thyroid axis, etc. Hypothetically, an abnormal response to certain infectious agents could trigger the development of post-infectious fatigue syndromes.es_ES
dc.language.isoenges_ES
dc.publisherAIDS Reviewses_ES
dc.relation.ispartofseries;vol. 24, nº 4
dc.relation.urihttps://www.aidsreviews.com/resumen.php?id=1616es_ES
dc.rightsopenAccesses_ES
dc.subjectchronic fatigue syndromees_ES
dc.subjectCOVID-19es_ES
dc.subjectlong-COVID;es_ES
dc.subjectmyalgic encephalomyelitises_ES
dc.subjectpersistent COVIDes_ES
dc.subjectpost-acute COVID-19 syndromees_ES
dc.subjectpost-infectious fatigue syndromees_ES
dc.subjectpost-viral fatiguees_ES
dc.subjectSARS-CoV-2es_ES
dc.subjectScopuses_ES
dc.subjectJCRes_ES
dc.titleIs SARS-CoV-2 the only cause of long-COVID?es_ES
dc.typeArticulo Revista Indexadaes_ES
reunir.tag~ARIes_ES
dc.identifier.doihttps://doi.org/10.24875/AIDSRev.22000025


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem